INBS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
INBS is not a good buy right now for a beginner long-term investor with $50,000-$100,000 ready to deploy. The technical setup is mixed-to-bearish, there is no supportive options/signal catalyst, no recent news, and the latest quarter still shows losses despite revenue growth. With the current pre-market price at 2.5, I would not treat this as an immediate buy; the better call is to hold and wait for clearer trend confirmation or stronger fundamental improvement.
Current pre-market price is 2.5, below the pivot at 2.687 and below resistance at 3.02, which keeps the stock under short-term pressure. The moving averages are bearish (SMA_200 > SMA_20 > SMA_5), indicating the broader trend remains weak. MACD histogram is positive and expanding, which is a short-term improvement, but RSI_6 at 37.787 is still neutral and does not confirm strong momentum. Key support is 2.355, then 2.15, while immediate resistance sits at 3.02. Overall, the technical picture is not strong enough to justify an aggressive long-term entry today.
["Revenue in 2026/Q2 increased 47.62% YoY to 896,774, showing strong top-line growth.", "MACD histogram is positive and expanding, suggesting some near-term momentum improvement.", "No recent negative news in the past week."]
["Net income remains deeply negative at -2,677,590 in 2026/Q2, so the business is still unprofitable.", "EPS fell to -2.82, showing earnings deterioration.", "Gross margin dropped sharply to 19.83, indicating weak profitability quality.", "Bearish moving average structure suggests the broader price trend is still down.", "No recent news-driven catalyst to support a re-rating.", "Hedge funds and insiders are both neutral, so there is no clear smart-money accumulation signal.", "No recent congress trading data available.", "Similar candlestick pattern analysis suggests a 60% chance of -1.63% next day and -2.02% next week."]
Latest quarter: 2026/Q2. Revenue grew 47.62% YoY to 896,774, which is a positive growth sign. However, the company is still loss-making with net income of -2,677,590, EPS of -2.82, and gross margin of 19.83. The growth trend is positive on revenue, but profitability remains weak and EPS/margin trends do not yet support a strong long-term buy case.
No analyst rating or price target data was provided, so there is no visible recent Wall Street upgrade/downgrade trend to assess. Based on the available data, Wall Street pros and cons lean cautious: the pro is strong revenue growth, while the con is continued losses, weak gross margin, and no fresh catalyst from analysts or news.
